BRIEF published on 09/18/2025 at 15:53, 2 months 16 days ago Novacyt nomme Singer Capital Markets comme co-courtier Cotation Boursière Novacyt Singer Capital Markets Co-courtier SP Angel
PRESS RELEASE published on 09/18/2025 at 15:50, 2 months 16 days ago Décision concernant les poursuites engagées par le HSE contre Lab 21 Résumé de la décision concernant les poursuites engagées par le HSE contre Lab 21, filiale de Novacyt. Lab 21 a plaidé coupable et payé une amende de £52,000 sans impact financier significatif sur le groupe Novacyt Amende Lab 21 HSE Poursuites
PRESS RELEASE published on 09/18/2025 at 15:48, 2 months 16 days ago Nomination d'un co-courtier pour l’entreprise Nomination d'un co-courtier Singer Capital Markets par Novacyt S.A. pour renforcer son équipe financière. Détails et contacts disponibles Finance D'entreprise Diagnostic Moléculaire Novacyt S.A. Singer Capital Markets Nouveau Co-courtier
BRIEF published on 07/28/2025 at 12:45, 4 months 7 days ago Novacyt Liquidity Contract Half-Yearly Review Liquidity Securities INVEST SECURITIES Sotck Exchange Novacyt
BRIEF published on 07/28/2025 at 12:45, 4 months 7 days ago Bilan Semestriel du Contrat de Liquidité de Novacyt Liquidité Bourse INVEST SECURITIES Titres Novacyt
PRESS RELEASE published on 07/28/2025 at 12:40, 4 months 7 days ago Liquidity Agreement Half Year Reporting H1 2025 Novacyt publie son bilan semestriel du contrat de liquidité confié à Invest Securities, avec 104 002 titres et 18 458,91€ en espèces échangés jusqu'au 30 juin 2025 Contrat De Liquidité Bilan Semestriel Actions INVEST SECURITIES Novacyt
BRIEF published on 07/15/2025 at 11:48, 4 months 20 days ago Lancement du LightBench® Discover par Novacyt Diagnostic Moléculaire Séquençage ADN Novacyt Lancement Produit LightBench® Discover
BRIEF published on 07/15/2025 at 11:48, 4 months 20 days ago Novacyt launches LightBench® Discover Product Launch DNA Sequencing Novacyt Molecular Diagnosis LightBench® Discover
PRESS RELEASE published on 07/15/2025 at 11:43, 4 months 20 days ago Lancement de LightBench® Discover Novacyt annonce le lancement de LightBench® Discover, un instrument 3-en-1 de haute précision pour la recherche génomique. Solution tout-en-un pour séquençage longue lecture HiFi. Note technique disponible en ligne Novacyt LightBench Discover Séquençage Longue Lecture Partenaires Compatibles PacBio Recherche Génomique
BRIEF published on 06/20/2025 at 13:19, 5 months 14 days ago Novacyt Confirme l'Adoption de Toutes les Résolutions lors de son AGA Stratégie D'entreprise Croissance Durable Résolutions Approuvées Novacyt Assemblé Générale
Published on 12/05/2025 at 02:35, 4 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 28 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 58 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 3 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 13 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 28 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 43 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
